Samsung Biologics Stock Price & Chart

KRX: 207940 · 삼성바이오로직스 · KOSPI

₩1,549,000▲ ₩4,000 (+0.26%)at close · July 28, 2026
1,987,0001,228,0001,549,000Jul 04, 25Oct 13Jan 15Apr 21Jul 28, 26

Samsung Biologics (삼성바이오로직스, KRX: 207940) last closed at ₩1,549,000 on July 28, 2026, a +0.26% move on the day. Over the trailing 52 weeks the stock has traded between ₩1,228,000 and ₩1,987,000, a +1.89% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩1,549,000
Day change+0.26%
52-week high₩1,987,000
52-week low₩1,228,000

Key Fundamentals

FY 2026.03
Market cap₩71.70T
P/E (PER)58.29
P/B (PBR)9.61
EPS₩26,572
BPS₩161,142
ROE19.56%
Debt ratio51.40%
Rev. growth25.77%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-28
BullishAlgorithmic summary of 5 standard indicators (net score +5). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 1,408,700
  • ▲ Bullish60-day MAPrice above 1,390,767
  • ▲ Bullish120-day MAPrice above 1,508,017
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • · NeutralRSI (14)RSI 62 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 42% of rangeRSI(14): 625-day volume vs 20-day: +92%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning Samsung Biologics

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.